A Controlled Trial of Erenumab in Migraine Prevention
Clinical trial NCT03812224 · COMPLETED
Trial details
- NCT number
- NCT03812224
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-12
- Primary completion
- 2020-03-16
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.